MYFEMBREE

relugolix, estradiol hemihydrate, and norethindrone acetate · Sumitomo Pharma America, Inc

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for MYFEMBREE, covering 2021-05-26 to 2025-09-29. Get the full timeline:

Most recent: Clinical Trial Update: Surgical Myomectomy Followed by Oral Myfembree Versus Standard of Care Trial (SOUL) [Phase 4]